[摘要] Cancer is a disease that predominantly affects older adults [
1,
2]. Older adults are very heterogeneous in terms of functional status [
3]. Moreover, in general, older adults are more vulnerable to medical problems that are iatrogenic in nature, and the presentation of illnesses in this population is often atypical [
4,
5]. There is currently limited evidence from clinical trials to inform practice because older adults have been underrepresented in clinical trials [
6]. Older adults have been overdiagnosed and overtreated, as well as underdiagnosed and undertreated, which impacts their health and well-being as well as the resources available [
7�?
20]. These factors combined necessitated the development and use of geriatric assessments (GA) in the oncology setting [
4].
